CARTEOLOL HYDROCHLORIDE

CARTEOLOL HYDROCHLORIDE was reported 333 times

CARTEOLOL HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FAILED FORCEPS DELIVERY 2 0.2500
1 GALLBLADDER HAEMATOMA 1 0.1250
2 HAEMORRHAGIC TUMOUR NECROSIS 1 0.0213
3 ATRIAL CONDUCTION TIME PROLONGATION 1 0.0196
4 HYPOZINCAEMIA 1 0.0169
5 OVARIAN FIBROMA 1 0.0156
6 MENINGIOMA SURGERY 1 0.0152
7 MACROPHAGES INCREASED 1 0.0149
8 AMYOTROPHY 5 0.0130
9 VITREORETINAL TRACTION SYNDROME 1 0.0105
10 CORNEAL EXFOLIATION 1 0.0098
11 GASTROOESOPHAGEAL CANCER 1 0.0093
12 RECTOSIGMOID CANCER 2 0.0091
13 ANTERIOR CHAMBER DISORDER 2 0.0087
14 EYELASH THICKENING 1 0.0083
15 CANDIDA ENDOPHTHALMITIS 1 0.0082
16 INSTILLATION SITE DRYNESS 1 0.0078
17 CORNEAL EROSION 4 0.0074
18 DACRYOCYSTITIS 1 0.0065
19 APOPTOSIS 2 0.0065
20 BLEPHARAL PIGMENTATION 3 0.0059
21 FLAT ANTERIOR CHAMBER OF EYE 1 0.0056
22 MONOCYTE PERCENTAGE DECREASED 1 0.0054
23 LID SULCUS DEEPENED 2 0.0054
24 IN-STENT CORONARY ARTERY RESTENOSIS 1 0.0052
25 EYELID SENSORY DISORDER 1 0.0051
26 GROWTH OF EYELASHES 4 0.0051
27 IRIS HYPERPIGMENTATION 1 0.0048
28 KERATITIS FUNGAL 1 0.0048
29 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 1 0.0043
30 PRIMARY BILIARY CHOLANGITIS 2 0.0043
31 PERIPHERAL VEIN THROMBOSIS 1 0.0042
32 TRI-IODOTHYRONINE FREE DECREASED 1 0.0039
33 CORNEAL THINNING 1 0.0039
34 INSTILLATION SITE ERYTHEMA 2 0.0038
35 LISTERIA SEPSIS 1 0.0038
36 ERYTHEMA ANNULARE 1 0.0034
37 REFRACTION DISORDER 1 0.0034
38 THYROIDITIS SUBACUTE 1 0.0034
39 XEROPHTHALMIA 2 0.0034
40 POOR DENTAL CONDITION 1 0.0034
41 LUNG INJURY 1 0.0033
42 PUPILLARY DISORDER 2 0.0033
43 CORNEAL PERFORATION 2 0.0032
44 TRICHIASIS 1 0.0031
45 PRINZMETAL ANGINA 3 0.0030
46 POSTERIOR CAPSULE OPACIFICATION 1 0.0029
47 ACTIVATION SYNDROME 1 0.0029
48 ANOXIA 1 0.0028
49 INTRAOCULAR PRESSURE TEST ABNORMAL 2 0.0028
50 CHRONIC RESPIRATORY DISEASE 1 0.0028
51 THYMOMA 1 0.0028
52 BOVINE TUBERCULOSIS 1 0.0026
53 LYMPHANGITIS 2 0.0025
54 SEPSIS NEONATAL 2 0.0025
55 BRADYCARDIA FOETAL 2 0.0024
56 SUPERFICIAL VEIN THROMBOSIS 2 0.0024
57 NODAL ARRHYTHMIA 2 0.0023
58 HEPATIC ATROPHY 1 0.0022
59 ADENOCARCINOMA OF COLON 4 0.0021
60 PRODUCT AFTER TASTE 2 0.0021
61 VITREOUS DISORDER 1 0.0021
62 DUODENAL PERFORATION 2 0.0020
63 GENITAL ERYTHEMA 1 0.0020
64 GLARE 1 0.0019
65 IRIS ADHESIONS 1 0.0019
66 INTRAOCULAR PRESSURE DECREASED 1 0.0019
67 IRIS DISORDER 1 0.0019
68 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
69 CORNEAL DISORDER 4 0.0018
70 OPHTHALMIC HERPES SIMPLEX 1 0.0017
71 CORNEAL EPITHELIUM DEFECT 1 0.0017
72 RETINAL VASCULAR DISORDER 1 0.0017
73 EYE BURNS 1 0.0017
74 HYPERTENSIVE ENCEPHALOPATHY 1 0.0017
75 INDUCED LABOUR 1 0.0017
76 SINOATRIAL BLOCK 1 0.0017
77 CARDIAC PROCEDURE COMPLICATION 1 0.0016
78 OPEN ANGLE GLAUCOMA 1 0.0016
79 DERMATOSIS 1 0.0016
80 NECROTISING RETINITIS 1 0.0016
81 OCULAR HYPERTENSION 3 0.0015
82 TONIC CLONIC MOVEMENTS 2 0.0015
83 TUMOUR FLARE 1 0.0015
84 STASIS DERMATITIS 1 0.0015
85 AORTITIS 1 0.0015
86 CENTRAL NERVOUS SYSTEM LYMPHOMA 2 0.0015
87 INTRAOCULAR PRESSURE INCREASED 18 0.0014
88 CONJUNCTIVAL HYPERAEMIA 5 0.0014
89 ANTERIOR CHAMBER CELL 1 0.0014
90 CREATINE KINASE INCREASED 1 0.0013
91 CYTOMEGALOVIRUS ENTEROCOLITIS 1 0.0013
92 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS 1 0.0013
93 NEONATAL DISORDER 2 0.0013
94 LYMPHOCYTE STIMULATION TEST POSITIVE 1 0.0012
95 BRONCHOPULMONARY DYSPLASIA 1 0.0012
96 GRANULOMA SKIN 1 0.0012
97 INSTILLATION SITE PAIN 3 0.0012
98 VITREOUS OPACITIES 1 0.0012
99 PRURIGO 1 0.0011
100 VITREOUS HAEMORRHAGE 3 0.0011
101 BIOPSY 1 0.0011
102 HEPATIC CONGESTION 1 0.0011
103 RETINAL VEIN OCCLUSION 3 0.0010
104 FEEDING DISORDER NEONATAL 1 0.0010
105 METASTASES TO PLEURA 1 0.0010
106 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0009
107 PERIODONTITIS 2 0.0009
108 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
109 INSTILLATION SITE IRRITATION 1 0.0008
110 UPPER RESPIRATORY TRACT INFLAMMATION 1 0.0008
111 NEUTROPHIL PERCENTAGE INCREASED 1 0.0008
112 ANGLE CLOSURE GLAUCOMA 2 0.0008
113 PHYSICAL DECONDITIONING 2 0.0008
114 LIP INJURY 1 0.0008
115 MACULAR HOLE 1 0.0007
116 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
117 CORNEAL OPACITY 1 0.0007
118 ISCHAEMIC HEPATITIS 1 0.0007
119 PERIPHERAL ARTERY OCCLUSION 1 0.0007
120 TONIC CONVULSION 1 0.0007
121 DARK CIRCLES UNDER EYES 1 0.0007
122 CONJUNCTIVITIS ALLERGIC 1 0.0007
123 KERATITIS 2 0.0007
124 IDIOPATHIC THROMBOCYTOPENIC PURPURA 1 0.0006
125 OPTIC ATROPHY 1 0.0006
126 OROPHARYNGEAL BLISTERING 1 0.0006
127 COLONIC POLYP 1 0.0006
128 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
129 CEREBELLAR INFARCTION 1 0.0006
130 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 3 0.0006
131 RETINITIS 1 0.0006
132 X-RAY ABNORMAL 1 0.0006
133 ERYTHEMA OF EYELID 3 0.0006
134 AMYLASE INCREASED 2 0.0005
135 RETINOPATHY 2 0.0005
136 TUNNEL VISION 1 0.0005
137 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
138 PURULENCE 1 0.0005
139 HYPERAEMIA 1 0.0005
140 CARDIAC DISCOMFORT 1 0.0005
141 QUADRIPLEGIA 1 0.0005
142 GASTROINTESTINAL PERFORATION 2 0.0005
143 FOETAL DISTRESS SYNDROME 1 0.0005
144 ABNORMAL SENSATION IN EYE 2 0.0005
145 DIABETIC NEPHROPATHY 1 0.0005
146 CARDIAC FAILURE ACUTE 3 0.0004
147 PERIPHERAL COLDNESS 6 0.0004
148 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
149 CONTRAST MEDIA REACTION 1 0.0004
150 PRE-ECLAMPSIA 2 0.0004
151 RETINAL TEAR 1 0.0004
152 PENIS DISORDER 1 0.0004
153 URINARY TRACT INFECTION BACTERIAL 1 0.0004
154 DERMATOMYOSITIS 1 0.0004
155 PARKINSON'S DISEASE 1 0.0004
156 GLAUCOMA 7 0.0004
157 DRUG TOLERANCE DECREASED 1 0.0004
158 RENAL TUBULAR DISORDER 1 0.0004
159 CATARACT OPERATION 2 0.0003
160 HEPATITIS FULMINANT 1 0.0003
161 BLOOD CULTURE POSITIVE 1 0.0003
162 CEREBROVASCULAR DISORDER 1 0.0003
163 VISUAL ACUITY REDUCED 11 0.0003
164 MYELOFIBROSIS 1 0.0003
165 PROSTATITIS 1 0.0003
166 BRAIN DEATH 1 0.0003
167 SWELLING OF EYELID 2 0.0003
168 BILE DUCT STONE 1 0.0003
169 FOREIGN BODY SENSATION IN EYES 2 0.0003
170 OEDEMA MOUTH 1 0.0003
171 HYPOGAMMAGLOBULINAEMIA 2 0.0003
172 CYTOLYTIC HEPATITIS 1 0.0003
173 THERAPEUTIC AGENT TOXICITY 1 0.0003
174 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
175 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
176 TOXIC SKIN ERUPTION 3 0.0003
177 EYELID PTOSIS 3 0.0003
178 DIABETIC RETINOPATHY 1 0.0003
179 BRONCHOPNEUMONIA 1 0.0003
180 LEFT VENTRICULAR FAILURE 1 0.0003
181 HAIR GROWTH ABNORMAL 2 0.0003
182 GRANULOMA 1 0.0003
183 EMBOLIC STROKE 1 0.0003
184 JAUNDICE CHOLESTATIC 1 0.0003
185 HAEMORRHAGIC DIATHESIS 1 0.0003
186 PYODERMA GANGRENOSUM 1 0.0003
187 FACIAL BONES FRACTURE 1 0.0003
188 DERMATITIS BULLOUS 2 0.0003
189 SPONDYLITIS 1 0.0003
190 CHRONIC SINUSITIS 1 0.0003
191 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
192 LIPASE INCREASED 2 0.0003
193 MATERNAL DRUGS AFFECTING FOETUS 2 0.0003
194 ATRIOVENTRICULAR BLOCK 2 0.0003
195 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
196 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
197 BLOOD ALBUMIN DECREASED 2 0.0003
198 ORGAN FAILURE 1 0.0002
199 MUSCLE DISORDER 2 0.0002
200 RECURRENT CANCER 1 0.0002
201 GOITRE 1 0.0002
202 HYPERURICAEMIA 1 0.0002
203 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
204 ESCHERICHIA INFECTION 2 0.0002
205 PULMONARY HYPERTENSION 5 0.0002
206 CATARACT 14 0.0002
207 PURULENT DISCHARGE 1 0.0002
208 VITAMIN D DECREASED 2 0.0002
209 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
210 IMMOBILE 1 0.0002
211 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
212 HAEMOGLOBIN INCREASED 1 0.0002
213 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
214 RENAL FUNCTION TEST ABNORMAL 1 0.0002
215 ERYTHEMA MULTIFORME 2 0.0002
216 SARCOIDOSIS 1 0.0002
217 BRADYCARDIA 11 0.0002
218 BODY TEMPERATURE DECREASED 2 0.0002
219 MULTIPLE DRUG OVERDOSE 1 0.0002
220 HYPOTHERMIA 2 0.0002
221 EYE PAIN 11 0.0002
222 BEHAVIOUR DISORDER 1 0.0002
223 BLOOD POTASSIUM INCREASED 3 0.0002
224 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
225 DEAFNESS UNILATERAL 1 0.0002
226 CHOKING SENSATION 1 0.0002
227 MACULAR OEDEMA 1 0.0002
228 ACUTE PULMONARY OEDEMA 1 0.0002
229 MYOCARDIAL ISCHAEMIA 2 0.0002
230 COLD SWEAT 3 0.0002
231 URINE ODOUR ABNORMAL 1 0.0002
232 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
233 COVID-19 PNEUMONIA 2 0.0002
234 PLEURISY 1 0.0002
235 LACRIMATION INCREASED 5 0.0002
236 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
237 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
238 GENERALISED OEDEMA 2 0.0002
239 CHOLANGITIS 1 0.0002
240 OLIGURIA 1 0.0002
241 ILEUS 2 0.0002
242 NASAL DRYNESS 1 0.0002
243 MYDRIASIS 2 0.0002
244 HAEMATOMA 4 0.0002
245 HEPATITIS ACUTE 1 0.0002
246 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
247 EYE HAEMORRHAGE 2 0.0001
248 UVEITIS 2 0.0001
249 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
250 NEPHROTIC SYNDROME 1 0.0001
251 RIGHT VENTRICULAR FAILURE 1 0.0001
252 PULMONARY TOXICITY 1 0.0001
253 RASH PUSTULAR 1 0.0001
254 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
255 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
256 LIVER DISORDER 6 0.0001
257 MEDICAL DEVICE COMPLICATION 1 0.0001
258 RASH MACULO-PAPULAR 3 0.0001
259 HEPATIC FUNCTION ABNORMAL 5 0.0001
260 AORTIC ANEURYSM 1 0.0001
261 ACIDOSIS 1 0.0001
262 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
263 HYPOALBUMINAEMIA 1 0.0001
264 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
265 MYASTHENIA GRAVIS 1 0.0001
266 SHOCK HAEMORRHAGIC 1 0.0001
267 VENTRICULAR TACHYCARDIA 2 0.0001
268 SECOND PRIMARY MALIGNANCY 1 0.0001
269 SKIN HYPERPIGMENTATION 1 0.0001
270 ANURIA 1 0.0001
271 PYELONEPHRITIS 1 0.0001
272 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
273 EOSINOPHILIA 2 0.0001
274 PRODUCT COMMUNICATION ISSUE 1 0.0001
275 DRUG ERUPTION 2 0.0001
276 HAEMARTHROSIS 1 0.0001
277 OSTEOMYELITIS 2 0.0001
278 OPTIC NEURITIS 1 0.0001
279 RESPIRATORY ARREST 3 0.0001
280 RETINAL DETACHMENT 1 0.0001
281 BLOOD SODIUM DECREASED 2 0.0001
282 EYE INFLAMMATION 1 0.0001
283 INCREASED APPETITE 2 0.0001
284 HYPERCHOLESTEROLAEMIA 1 0.0001
285 SINUS BRADYCARDIA 1 0.0001
286 DIZZINESS POSTURAL 1 0.0001
287 VITREOUS FLOATERS 1 0.0001
288 NEUTROPHIL COUNT INCREASED 1 0.0001
289 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
290 POLLAKIURIA 4 0.0001
291 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
292 FULL BLOOD COUNT ABNORMAL 1 0.0001
293 EYE PRURITUS 3 0.0001
294 RASH PAPULAR 2 0.0001
295 INTESTINAL PERFORATION 1 0.0001
296 OCULAR DISCOMFORT 1 0.0001
297 HYPONATRAEMIA 5 0.0001
298 CHROMATURIA 2 0.0001
299 EYE INFECTION 1 0.0001
300 STATUS EPILEPTICUS 1 0.0001
301 SCAB 1 0.0001
302 HAEMATURIA 3 0.0001
303 ELECTROLYTE IMBALANCE 1 0.0001
304 CAESAREAN SECTION 1 0.0001
305 HYPERKALAEMIA 3 0.0001
306 HYPOXIA 3 0.0001
307 OCULAR HYPERAEMIA 4 0.0001
308 BACTERAEMIA 1 0.0001
309 MACULAR DEGENERATION 1 0.0001
310 NOCTURIA 1 0.0001
311 CEREBRAL INFARCTION 2 0.0001
312 RESPIRATORY DEPRESSION 1 0.0001
313 HYPERCALCAEMIA 1 0.0001
314 EYE SWELLING 3 0.0001
315 PNEUMONIA ASPIRATION 2 0.0001
316 BRAIN OEDEMA 1 0.0001
317 ROTATOR CUFF SYNDROME 1 0.0001
318 ANAPHYLACTIC SHOCK 2 0.0001
319 BLOOD CREATININE INCREASED 5 0.0001
320 PRODUCT TASTE ABNORMAL 1 0.0001
321 DRUG TOXICITY 1 0.0001
322 GINGIVAL BLEEDING 1 0.0001
323 CORONARY ARTERY OCCLUSION 1 0.0001
324 SKIN LESION 2 0.0001
325 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
326 RHABDOMYOLYSIS 3 0.0001
327 CARPAL TUNNEL SYNDROME 1 0.0001
328 SKIN REACTION 1 0.0001
329 BLINDNESS UNILATERAL 1 0.0001
330 RENAL FAILURE ACUTE 3 0.0001
331 GASTROENTERITIS 1 0.0001
332 NASAL CONGESTION 4 0.0001
333 ACUTE MYOCARDIAL INFARCTION 2 0.0001
334 URINARY INCONTINENCE 2 0.0001
335 PULMONARY OEDEMA 3 0.0001
336 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
337 DEVICE FAILURE 1 0.0001
338 SKIN DISCOLOURATION 3 0.0001
339 PHARYNGEAL OEDEMA 1 0.0001
340 TENDONITIS 1 0.0001
341 MENINGIOMA 1 0.0001
342 METABOLIC ACIDOSIS 2 0.0001
343 SENSORY DISTURBANCE 1 0.0001
344 NIGHT SWEATS 2 0.0001
345 ATRIAL FIBRILLATION 6 0.0001
346 MUSCULAR WEAKNESS 7 0.0001
347 DRUG LEVEL INCREASED 1 0.0001
348 BLOOD UREA INCREASED 1 0.0001
349 CELLULITIS 3 0.0001
350 SKIN EXFOLIATION 5 0.0001
351 INFLAMMATION 3 0.0001
352 ORTHOSTATIC HYPOTENSION 1 0.0001
353 METASTASES TO LIVER 1 0.0001
354 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
355 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
356 SYNOVITIS 1 0.0001
357 OEDEMA 3 0.0001
358 LEUKOCYTOSIS 1 0.0001
359 DYSURIA 2 0.0001
360 SEPSIS 6 0.0001
361 BACTERIAL INFECTION 1 0.0001
362 OXYGEN SATURATION DECREASED 3 0.0001
363 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
364 HYPOCALCAEMIA 1 0.0001
365 PULMONARY FIBROSIS 1 0.0001
366 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
367 EYE IRRITATION 3 0.0001
368 CHOLESTASIS 1 0.0001
369 EAR PAIN 1 0.0001
370 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
371 HAEMORRHOIDS 1 0.0001
372 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
373 DISORIENTATION 2 0.0001
374 CYTOKINE RELEASE SYNDROME 1 0.0000
375 TASTE DISORDER 1 0.0000
376 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
377 CARDIAC ARREST 4 0.0000
378 PERITONITIS 1 0.0000
379 CARDIO-RESPIRATORY ARREST 2 0.0000
380 RENAL IMPAIRMENT 4 0.0000
381 HALLUCINATION, VISUAL 1 0.0000
382 PRURITUS GENERALISED 1 0.0000
383 MUSCULOSKELETAL STIFFNESS 4 0.0000
384 MELAENA 1 0.0000
385 RENAL FAILURE 6 0.0000
386 SNEEZING 1 0.0000
387 THROAT IRRITATION 2 0.0000
388 HEART RATE IRREGULAR 1 0.0000
389 APPLICATION SITE PRURITUS 1 0.0000
390 VISION BLURRED 6 0.0000
391 SHOCK 1 0.0000
392 PERICARDIAL EFFUSION 1 0.0000
393 RENAL DISORDER 2 0.0000
394 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
395 ARRHYTHMIA 2 0.0000
396 DISEASE RECURRENCE 2 0.0000
397 PRODUCT PRESCRIBING ERROR 1 0.0000
398 ANAEMIA 8 0.0000
399 INTERSTITIAL LUNG DISEASE 2 0.0000
400 PRESYNCOPE 1 0.0000
401 LUNG DISORDER 2 0.0000
402 VISUAL IMPAIRMENT 5 0.0000
403 AGEUSIA 1 0.0000
404 DRY EYE 2 0.0000
405 LEUKOPENIA 2 0.0000
406 SYNCOPE 4 0.0000
407 CARDIOVASCULAR DISORDER 1 0.0000
408 HYPOPHAGIA 1 0.0000
409 HEPATITIS 1 0.0000
410 HYPERHIDROSIS 5 0.0000
411 SKIN ULCER 1 0.0000
412 PARAESTHESIA 6 0.0000
413 PLATELET COUNT DECREASED 4 0.0000
414 BLOOD BILIRUBIN INCREASED 1 0.0000
415 LIMB INJURY 1 0.0000
416 PALLOR 1 0.0000
417 PNEUMONITIS 1 0.0000
418 PROCEDURAL PAIN 1 0.0000
419 ASTHMA 4 0.0000
420 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
421 ANGINA PECTORIS 1 0.0000
422 HYPERSOMNIA 1 0.0000
423 PANCREATIC CARCINOMA 1 0.0000
424 DECREASED APPETITE 8 0.0000
425 LIVER FUNCTION TEST ABNORMAL 1 0.0000
426 BONE PAIN 2 0.0000
427 ASCITES 1 0.0000
428 BLOOD POTASSIUM DECREASED 1 0.0000
429 APHASIA 1 0.0000
430 DISCOMFORT 2 0.0000
431 CARDIAC DISORDER 3 0.0000
432 DRUG-INDUCED LIVER INJURY 1 0.0000
433 PULMONARY EMBOLISM 3 0.0000
434 HYPOTHYROIDISM 1 0.0000
435 MOVEMENT DISORDER 1 0.0000
436 DEEP VEIN THROMBOSIS 2 0.0000
437 IMPAIRED HEALING 1 0.0000
438 OSTEONECROSIS 1 0.0000
439 URINARY RETENTION 1 0.0000
440 TYPE 2 DIABETES MELLITUS 1 0.0000
441 MALAISE 13 0.0000
442 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
443 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
444 DELIRIUM 1 0.0000
445 BURNING SENSATION 2 0.0000
446 HEART RATE DECREASED 1 0.0000
447 SLEEP DISORDER 2 0.0000
448 HYPERTENSION 6 0.0000
449 OVERDOSE 6 0.0000
450 MYELOSUPPRESSION 1 0.0000
451 CRYING 1 0.0000
452 C-REACTIVE PROTEIN INCREASED 1 0.0000
453 MUSCLE SPASMS 5 0.0000
454 DYSPNOEA EXERTIONAL 1 0.0000
455 COLITIS 1 0.0000
456 CHRONIC KIDNEY DISEASE 2 0.0000
457 BLOOD PRESSURE INCREASED 4 0.0000
458 PALPITATIONS 3 0.0000
459 CHILLS 3 0.0000
460 CARDIAC FAILURE CONGESTIVE 2 0.0000
461 ROAD TRAFFIC ACCIDENT 1 0.0000
462 CONDITION AGGRAVATED 7 0.0000
463 MYOCARDIAL INFARCTION 4 0.0000
464 NEUTROPENIA 3 0.0000
465 NEPHROLITHIASIS 1 0.0000
466 HYPOKALAEMIA 1 0.0000
467 BLOOD CHOLESTEROL INCREASED 1 0.0000
468 FALL 7 0.0000
469 COMA 1 0.0000
470 RASH ERYTHEMATOUS 1 0.0000
471 HYPOGLYCAEMIA 1 0.0000
472 PYREXIA 7 0.0000
473 AGGRESSION 1 0.0000
474 CHEST DISCOMFORT 2 0.0000
475 ERYTHEMA 4 0.0000
476 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
477 HAEMORRHAGE 2 0.0000
478 ECZEMA 1 0.0000
479 DRUG INTERACTION 3 0.0000
480 INSOMNIA 5 0.0000
481 ASTHENIA 7 0.0000
482 DRUG EFFECT DECREASED 1 0.0000
483 PANCYTOPENIA 1 0.0000
484 THROMBOCYTOPENIA 2 0.0000
485 CONVULSION 1 0.0000
486 HERPES ZOSTER 1 0.0000
487 PRODUCT SUBSTITUTION ISSUE 1 0.0000
488 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
489 BACK PAIN 4 0.0000
490 DYSPHONIA 1 0.0000
491 BLADDER CANCER 1 0.0000
492 THERAPEUTIC RESPONSE DECREASED 1 0.0000
493 STOMATITIS 1 0.0000
494 ILL-DEFINED DISORDER 1 0.0000
495 HYPERSENSITIVITY 3 0.0000
496 DIZZINESS 8 0.0000
497 RHINORRHOEA 1 0.0000
498 PNEUMONIA 5 0.0000
499 PRODUCT DOSE OMISSION 1 0.0000
500 INFUSION RELATED REACTION 1 0.0000
501 FEBRILE NEUTROPENIA 1 0.0000
502 BLOOD PRESSURE DECREASED 1 0.0000
503 HYPOTENSION 3 0.0000
504 HEPATIC ENZYME INCREASED 1 0.0000
505 ABDOMINAL PAIN UPPER 3 0.0000
506 MEMORY IMPAIRMENT 2 0.0000
507 WEIGHT DECREASED 4 0.0000
508 DEVICE MALFUNCTION 1 0.0000
509 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
510 DIARRHOEA 9 0.0000
511 CONSTIPATION 3 0.0000
512 RESPIRATORY FAILURE 1 0.0000
513 UNDERDOSE 1 0.0000
514 DYSGEUSIA 1 0.0000
515 WEIGHT INCREASED 3 0.0000
516 EPISTAXIS 1 0.0000
517 DIABETES MELLITUS 1 0.0000
518 VOMITING 6 0.0000
519 ARTHRITIS 1 0.0000
520 OFF LABEL USE 11 0.0000
521 INJECTION SITE HAEMORRHAGE 1 0.0000
522 CARDIAC FAILURE 1 0.0000
523 DRY MOUTH 1 0.0000
524 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
525 COMPLETED SUICIDE 1 0.0000
526 URTICARIA 2 0.0000
527 INTENTIONAL PRODUCT MISUSE 1 0.0000
528 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
529 OROPHARYNGEAL PAIN 1 0.0000
530 CHEST PAIN 2 0.0000
531 COUGH 3 0.0000
532 SWELLING 1 0.0000
533 PRODUCT USE ISSUE 2 0.0000
534 DRUG INEFFECTIVE 14 0.0000
535 DYSPHAGIA 1 0.0000
536 PRURITUS 4 0.0000
537 CONTUSION 1 0.0000
538 DRUG INTOLERANCE 1 0.0000
539 DYSPEPSIA 1 0.0000
540 NAUSEA 8 0.0000
541 SOMNOLENCE 2 0.0000
542 HAEMOGLOBIN DECREASED 1 0.0000
543 ARTHRALGIA 4 0.0000
544 ABDOMINAL DISTENSION 1 0.0000
545 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
546 DYSPNOEA 5 0.0000
547 SEIZURE 1 0.0000
548 DISEASE PROGRESSION 1 0.0000
549 FEELING ABNORMAL 2 0.0000
550 OEDEMA PERIPHERAL 1 0.0000
551 HEADACHE 5 0.0000
552 LOSS OF CONSCIOUSNESS 1 0.0000
553 PSORIASIS 1 0.0000
554 DEHYDRATION 1 0.0000
555 ANXIETY 2 0.0000
556 DEATH 6 0.0000
557 INFECTION 1 0.0000
558 ACUTE KIDNEY INJURY 1 0.0000
559 PAIN 4 0.0000
560 PERIPHERAL SWELLING 1 0.0000
561 TREMOR 1 0.0000
562 TOXICITY TO VARIOUS AGENTS 1 0.0000
563 MYALGIA 1 0.0000
564 COVID-19 1 0.0000
565 NASOPHARYNGITIS 1 0.0000
566 BLOOD GLUCOSE INCREASED 1 0.0000
567 GAIT DISTURBANCE 1 0.0000
568 FATIGUE 4 0.0000
569 ALOPECIA 1 0.0000
570 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
571 DEPRESSION 1 0.0000
572 INCORRECT DOSE ADMINISTERED 1 0.0000
573 ABDOMINAL PAIN 1 0.0000
574 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
575 PAIN IN EXTREMITY 1 0.0000
576 INJECTION SITE PAIN 1 0.0000
577 RASH 1 0.0000